DARE
NASDAQ
$1.34
Dare Bioscience Inc (DARE)
Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $9.67 (+621.64%)
Market Cap
$30M
Free Cash Flow Yield
-34.74%
Beta (5Y)
0.54
Price Chart
Valuation
Market Cap$30M
Forward P/E1.27
P/S26.79
P/B42.46
Profitability
Total Revenue (TTM)$1.16M
Gross Profit (TTM)$2.26M
EBITDA-$9.96M
Operating Margin-1967%
EPS-$1.01
Financial Health
Free Cash Flow Yield-34.74%
Growth & Risk
EPS 5Y CAGR-36.35%
Revenue 5Y CAGR+9.62%
FCF 5Y CAGR-17.77%
Beta (5Y)0.54
Sharpe Ratio-0.22